Sea lice exposure to non-lethal levels of emamectin benzoate after treatments: a potential risk factor for drug resistance
(2020)
Journal Article
Lam, C. T., Rosanowski, S. M., Walker, M., & St-Hilaire, S. (2020). Sea lice exposure to non-lethal levels of emamectin benzoate after treatments: a potential risk factor for drug resistance. https://doi.org/10.1038/s41598-020-57594-7
The avermectin derivative emamectin benzoate (EMB) has been widely used by salmon industries around the world to control sea lice infestations. Resistance to this anti-parasitic drug is also commonly reported in these industries. The objective of thi... Read More about Sea lice exposure to non-lethal levels of emamectin benzoate after treatments: a potential risk factor for drug resistance.